State Of Alaska, Department Of Revenue Seagen Inc. Transaction History

State Of Alaska, Department Of Revenue

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	SELL	$108.81 - $179.33 $1.15 Million - $1.89 Million	-10,537 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$119.61 - $157.85 $124,992 - $164,953	-1,045 Reduced 9.02%	10,537 $1.52 Million
Q4 2021 Jan 12, 2022	SELL	$142.57 - $190.86 $226,116 - $302,703	-1,586 Reduced 12.04%	11,582 $1.79 Million
Q3 2021 Oct 07, 2021	SELL	$142.45 - $169.82 $105,555 - $125,836	-741 Reduced 5.33%	13,168 $2.24 Million
Q2 2021 Jul 12, 2021	SELL	$135.08 - $161.1 $2.39 Million - $2.85 Million	-17,719 Reduced 56.02%	13,909 $2.2 Million
Q1 2021 Apr 09, 2021	SELL	$137.51 - $190.8 $62,292 - $86,432	-453 Reduced 1.41%	31,628 $4.39 Million
Q4 2020 Jan 08, 2021	BUY	$164.63 - $211.93 $5.28 Million - $6.8 Million	32,081 New	32,081 $5.62 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.